Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-11

Clinical Trial Update: Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating Verubulin in combination with Temozolomide and radiation therapy for newly diagnosed glioblastoma multiforme. The study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temodar (Temozolomide)
  • Verubulin (ABT-751)

Snippet

Sponsor: Myrexis Inc. | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED